Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/20/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 607 publications

Sintilimab plus autologous NK cells as second-line treatment for advanced non-small-cell lung cancer previous treated with platinum-containing chemotherapy.

Condition: Non-Small Cell Lung Cancer (NSCLC)
Journal: Frontiers in immunology
Treatment Used: Sintilimab Plus Autologous NK Cells
Number of Patients: 20
Published: December 26, 2022

Assessment of efficacy and safety of volanesorsen for treatment of metabolic complications in patients with familial partial lipodystrophy: Results of the BROADEN study: Volanesorsen in FPLD; The BROADEN Study.

Condition: Familial Partial Lipodystrophy (FPLD) and Concomitant Hypertriglyceridemia and Diabetes
Journal: Journal of clinical lipidology
Treatment Used: Volanesorsen
Number of Patients: 40
Published: November 19, 2022

Tolerance and response to ketogenic therapy in neonates and infants younger than 4 months. Case series in a hospital center in Medellin, Colombia.

Condition: Neonates with Refractory Epilepsy
Journal: Revista de neurologia
Treatment Used: Ketogenic Therapy (KT)
Number of Patients: 7
Published: November 10, 2022

Anlotinib plus chemotherapy for T790M-negative EGFR-mutant non-sqNSCLC resistant to TKIs: A multicenter phase 1b/2 trial.

Condition: T790M-Negative EGFR-Mutant Non-Squamous Cell Non-Small Cell Lung Cancer (NSCLC)
Journal: Thoracic cancer
Treatment Used: Anlotinib Plus Chemotherapy
Number of Patients: 19
Published: November 08, 2022

Increase in range of motion after intra-articular injection of triamcinolone acetonide for the treatment of frozen shoulder is related to body mass index.

Condition: Frozen Shoulder
Journal: Joint diseases and related surgery
Treatment Used: Intra-Articular Injection of Triamcinolone Acetonide
Number of Patients: 305
Published: November 08, 2022

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.

Condition: Hypertriglyceridemia
Journal: The New England journal of medicine
Treatment Used: Pemafibrate
Number of Patients: 10497
Published: November 07, 2022

Assessment of Statin Treatment for Pulmonary Alveolar Proteinosis without Hypercholesterolemia: A 12-Month Prospective, Longitudinal, and Observational Study.

Condition: Pulmonary Alveolar Proteinosis (PAP)
Journal: BioMed research international
Treatment Used: Statin Therapy
Number of Patients: 47
Published: November 04, 2022

Efficacy and Safety of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia: Phase 3, Multinational Open-Label Study.

Condition: Children and Adolescents With Homozygous Familial Hypercholesterolemia
Journal: Arteriosclerosis, thrombosis, and vascular biology
Treatment Used: Alirocumab
Number of Patients: 18
Published: November 03, 2022

Perioperative Management and Clinical Outcomes of Liver Transplantation for Children with Homozygous Familial Hypercholesterolemia.

Condition: Children with Homozygous Familial Hypercholesterolemia (HoFH)
Journal: Medicina (Kaunas, Lithuania)
Treatment Used: Liver Transplantation (LT)
Number of Patients: 0
Published: October 27, 2022

Long-term safety and efficacy of MND-2119 (self-emulsifying formulation of highly purified eicosapentaenoic acid ethyl ester) in patients with hypertriglyceridemia: Results from a multicenter, 52-week, open-label study.

Condition: Hypertriglyceridemia
Journal: Journal of clinical lipidology
Treatment Used: MND-2119
Number of Patients: 0
Published: October 06, 2022

Effects of curcumin and/or coenzyme Q10 supplementation on metabolic control in subjects with metabolic syndrome: a randomized clinical trial.

Condition: Metabolic Syndrome (Mets)
Journal: Nutrition journal
Treatment Used: Curcumin and/or Coenzyme Q10 Supplementation
Number of Patients: 88
Published: October 03, 2022

mTORi-based immunosuppression reduces HCC recurrence at the expense of increased adverse side effects: A systematic review and meta-analysis.

Condition: Hepatocellular Carcinoma (HCC)
Journal: Clinical transplantation
Treatment Used: Mammalian Target of Rapamycin Inhibitors mTORI) vs. Calcineurin Inhibitors (CNI)
Number of Patients: 10607
Published: September 20, 2022
Showing 1-12 of 607

Last Updated: 01/20/2023